GoKawiil
Novartis to Buy Allergy-Drug Developer Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
1.
2.
Novartis to Buy Biotech Excellergy for Up to $2 Billion
(feeds.content.dowjones.io)
3.
Novartis to Buy Breast-Cancer Drug From Synnovation for Up to $3 Billion
(feeds.content.dowjones.io)
4.
The Day Novartis Chose Discovery
(news.ycombinator.com)